跳至主要内容
临床试验/NCT06347783
NCT06347783尚未招募不适用

The Effect of Automated Insulin Delivery on Sleep Compared to Multiple Daily Injections in Pediatric Patients With Type 1 Diabetes

Oregon Health and Science University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
80
试验地点
1
主要终点
Sleep duration

研究概览

简要总结

The purpose of the study is to learn about the effect of insulin pumps on sleep in pediatric patients with type 1 diabetes and their caregivers. We are hoping to find out if insulin pumps improve sleep, worsen sleep, or have no effect at all. We are hoping to also explore the relationship between insulin pumps, sleep, and overnight blood sugar control. Your information will not be stored and used for future research.

The goal of this observational study is learn about the effect of insulin pumps on sleep in pediatric patients with type 1 diabetes and their caregivers. The main questions it aims to answer are:

Do insulin pumps improve sleep, worsen sleep or have no effect at all? What is the relationship between insulin pumps, sleep, and overnight blood sugar control?

Participants will be asked to:

  • Complete questionnaires regarding demographic data and diabetes history.
  • Complete surveys regarding sleep quality before and after starting an insulin pump.
  • Wear a FitBit during sleep for 2 weeks and fill out daily sleep diaries over a 2 week period prior to starting an insulin pump.

After 1-2 months after initiation of an insulin pump, participants will be asked again to:

  • Complete surveys regarding sleep quality
  • Wear a FitBit during sleep for 2 weeks
  • Fill out daily sleep diaries over the same 2 week period.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
6 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • i. Diagnosis: Type 1 diabetes for at least 6 months ii. Age: Participants must be aged between 6-18 years at time of enrollment iii. Treatment modality: Participants must be currently receiving treatment for Type 1 Diabetes through multiple daily injections of insulin, with concomitant use of a continuous glucose monitor, with data sharing through Clarity. Participants must be eligible for an insulin pump, based on individual provider discretion.
  • iv. Smartphone access, ability to download FitBit application. v. Language: Participants and their guardians must be able to understand and communicate in the primary language(s) used for study-related instructions and questionnaires, which include a demographic survey, questions about diabetes history, two surveys regarding patient and caregiver sleep, and a daily sleep diary.
  • vi. Informed Consent: Participants (if aged 18 or older) or their legal guardians must provide informed consent for participation in the study.

排除标准

  • i. Diagnosis: Participants with a diagnosis other than Type 1 Diabetes (e.g. Type 2 Diabetes or MODY).
  • ii. Age: Participants outside the age range of 6 to 18 years. iii. Treatment modality:
  • Participants currently not receiving multiple daily injections of insulin.
  • Participants currently not using a continuous glucose monitor. iv. Participants ineligible for an insulin pump. v. No access to smartphone vi. Inadequate language proficiency: Participants or guardians that cannot communicate effectively in the primary study language.
  • vii. If a participant is otherwise eligible for the study, a modification may be submitted to the IRB to include the participant in the study. However, language barrier is not an obstacle for a patient to receive standard care in the clinic.
  • viii. Pregnancy: Pregnancy can significantly affect insulin requirements and sleep patterns.
  • ix. Allergy or Sensitivity: Participants with known allergies or sensitivities to materials used in Fitbit devices or related equipment.

结局指标

主要结局

Sleep duration

时间窗: 4 months

Number of hours and minutes measured by FitBit

Sleep efficiency

时间窗: 4 months

The percentage of time spent asleep while in bed, calculated as the ratio of total sleep time to total time spent in bed.

次要结局

  • Sleep Disturbance Scale for Children(4 months)
  • Promis Short Form 8a(4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rachel Palting

Pediatric endocrinology fellow

Oregon Health and Science University

研究点 (1)

Loading locations...

相似试验